Treats hypertension. ANDA 70974, held by Actavis Elizabeth. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 70974 (Clonidine Hydrochloride), held by Actavis Elizabeth, was first approved by FDA on Dec 16, 1986, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Clonidine hydrochloride tablets are indicated in the treatment of hypertension. Clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 16, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clonidine Hydrochloride0.1MG · tablet;oral | Clonidine Hydrochloride | Rx |
| Jan 16, 2013 | Supplement 40Labeling · Standard review | Approved | None posted |
| Jun 23, 2010 | Supplement 34Labeling | Approved | None posted |
| Aug 8, 2002 | Supplement 16Manufacturing | Approved | None posted |
| Nov 2, 2001 | Supplement 15Manufacturing | Approved | None posted |
| Mar 20, 2000 | Supplement 13Manufacturing | Approved | None posted |
| Mar 20, 2000 | Supplement 14Manufacturing | Approved | None posted |
| Feb 18, 1997 | Supplement 12Labeling | Approved | None posted |
| Jan 18, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Feb 4, 1992 | Supplement 9Manufacturing | Approved | None posted |
| Nov 21, 1990 | Supplement 7Manufacturing | Approved | None posted |
| Oct 13, 1989 | Supplement 8Labeling | Approved | None posted |
| Nov 17, 1988 | Supplement 5Labeling | Approved | None posted |
| Nov 17, 1988 | Supplement 6Labeling | Approved | None posted |
| Jan 28, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Jun 9, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Jun 9, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Dec 16, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters